Overview
- AstraZeneca on Friday, October 30, 2026 launched the three‑year “Reshaping for Sustainable Growth” programme that will cost up to $2bn and aims to deliver $1.5bn in annual savings for reinvestment.
- The move accompanied stronger‑than‑expected third‑quarter results, with group revenue up 7% to $16.2bn and net profit rising about 23% to $3.12bn.
- Executives said the programme will reorganise roles and use more technology, and that some jobs will be cut in specific areas while overall headcount is not expected to fall.
- Investors reacted positively, sending AstraZeneca shares noticeably higher after the announcement as markets priced the savings and renewed focus on growth.
- The company said the cash will back more than 180 pipeline projects, targeted late‑stage launches and recent partnerships and investments — including US market access and expanded China ties — as it seeks to mitigate patent losses and hit its 2030 goal.